在创伤后的危急疾病期间,肠道服药后血β-基β-甲基酸盐的可用性:一项探索性研究
Kym Wittholz1,2, Amy J Bongetti3, Kate Fetterplace1,2
1Department of Allied Health (Clinical Nutrition), Royal Melbourne Hospital, Melbourne, Australia.
JPEN. Journal of parenteral and enteral nutrition
|March 24, 2024
概括
接受肠道β-基β-甲基酸盐 (HMB) 治疗的重症患者表现出血HMB水平的增加. 由于研究的局限性,肌肉HMB度需要进一步调查.
科学领域:
- 关键护理医学 关键护理医学
- 营养科学 营养科学
- 代谢过程中的代谢.
背景情况:
- 骨肌肉消耗是严重疾病的快速后果.
- 贝塔-基-贝塔-甲基酸盐 (HMB) 作为一种潜在的对策正在研究中.
- 关于HMB在重症患者的血和肌肉度存在不确定性.
研究的目的:
- 在危急病患者中探索肠道HMB的血外观和肌肉度.
- 评估HMB补充剂在这个患者群体中的疗效.
主要方法:
- 一个探索性的,双盲的,随机的临床试验.
- 重症创伤患者每天接受肠道HMB (3g) 或安慰剂.
- 血样本在给药后的时间间隔内收集.
- 在基线和干预期间获得了Vastus lateralis肌肉活检.
主要成果:
- 肠道HMB在60分钟内显著增加了血HMB度.
- 基线肌肉HMB度在各组之间相似.
- 肌肉HMB水平在HMB给药后4小时内进行活检时更高.
结论:
- 肠道HMB的使用有效地增加了重症患者的血HMB可用性.
- 样本的小规模限制了关于肌肉HMB积累的最终结论.
相关概念视频
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K
Parenteral Anesthetics: Overview
120
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
120
Drug Distribution: Plasma Protein Binding
5.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.6K
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
127
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
127
Drug Delivery: Enteral Route
437
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
437


